A specific opiate antagonist that has no agonist activity. It is a competitive antagonist at mu, delta, and kappa opioid receptors.
Definition (CSP)
specific opiate antagonist with no agonist activity, a competitive antagonist at mu, delta, and kappa opioid receptors.
Definition (NCI)
A substance that is being studied as a treatment for constipation caused by narcotic medications. It belongs to the family of drugs called narcotic antagonists.
Definition (NCI)
A thebaine derivate with competitive opioid antagonistic properties. Naloxone reverses the effects of opioid analgesics by binding to the opioid receptors in the CNS, and inhibiting the typical actions of opioid analgesics, including analgesia, euphoria, sedation, respiratory depression, miosis, bradycardia, and physical dependence. Naloxone binds to mu-opioid receptors with a high affinity, and a lesser degree to kappa- and gamma-opioid receptors in the CNS.
Concepts
Organic Chemical (T109)
, Pharmacologic Substance (T121)
Organic Chemical (T109)
, Pharmacologic Substance (T121)
MSH
D009270
English
Narcan Neonatal, narcan, Narcanti, Boots Brand of Naloxone Hydrochloride, Bristol Myers Squibb Brand of Naloxone Hydrochloride, Bristol-Myers Squibb Brand of Naloxone Hydrochloride, Endo Brand of Naloxone Hydrochloride, Lamepro Brand of Naloxone Hydrochloride, United Drug Brand of Naloxone Hydrochloride, Narcan